Skip to main content
All lobbying filings

W STRATEGIES, LLC

Lobbying for INCYTE CORPORATION · ​Biopharmaceutical Company.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · $60,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 1
 Lobbying activity 1
Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem